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The surgical reconstruction of ureteric defects is often associated with post-operative 
complications and requires additional medical care. Decellularized ureters originating 
from porcine donors could represent an alternative therapy. Our aim was to investigate 
the possibility of manufacturing decellularized ureters, the characteristics of the 
extracellular matrix (ECM) and the biocompatibility of these grafts in  vitro/in  vivo 
after treatment with different crosslinking agents. To achieve these goals, native 
ureters were obtained from pigs and were decellularized. The success of decel-
lularization and the ECM composition were characterized by (immuno)histological 
staining methods and a DNA-assay. In vitro: scaffolds were crosslinked either with 
carbodiimide (CDI), genipin (GP), glutaraldehyde, left chemically untreated or were 
lyophilized. Scaffolds in each group were reseeded with Caco2, LS48, 3T3 cells, or 
native rat smooth muscle cells (SMC). After 2 weeks, the number of ingrown cells 
was quantified. In vivo: crosslinked scaffolds were implanted subcutaneously into 
rats and the type of infiltrating cells were determined after 1, 9, and 30 days. After 
decellularization, scaffold morphology and composition of ECM were maintained, all 
cellular components were removed, DNA destroyed and strongly reduced. In vitro: 
GP and CDI scaffolds revealed a higher number of ingrown 3T3 and SMC cells as 
compared to untreated scaffolds. In vivo: at day 30, implants were predominantly 
infiltrated by fibroblasts and M2 anti-inflammatory macrophages. A maximum of MMP3 
was observed in the CDI group at day 30. TIMP1 was below the detection limit. In 
this study, we demonstrated the potential of decellularization to create biocompatible 
porcine ureteric grafts, whereas a CDI-crosslink may facilitate the remodeling process. 
The use of decellularized ureteric grafts may represent a novel therapeutic method 
in reconstruction of ureteric defects.
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introduction
The surgical removal of tissues or organs is an aggressive therapeu-
tic strategy to treat innate or acquired pathologies of the urinary 
tract. Surgical removal will present the patient and surgeon with 
challenges in the reconstruction of the excretory function of the 
urinary tract. In the case of extensive ureteral resection, surgical 
reconstruction by means of end-to-end anastomoses remains a 
major issue. Various surgical techniques were employed such as 
the psoas hitch (Warwick and Worth, 1969), the Boari flap (Boari, 
1894) and the downward mobilization of the respective kidney 
(Sullivan et al., 1982), as well as the replacement of the ureters 
with ileal or bladder tissue or even nephrectomy (del Pizzo et al., 
1998; Corvin et al., 2004; Schlote et al., 2004; Wolff et al., 2011; 
Takeuchi et al., 2014). These surgical techniques were frequently 
accompanied by serious complications, ranging from mucus 
formation, stenosis, and infection to renal failure (Corvin et al., 
2004; Schlote et al., 2004; Wolff et al., 2011). To circumvent these 
complications, tissue-engineered scaffolds may be an alternative 
in the surgical reconstruction of the urinary tract.
Recently, various types of synthetic or biologic scaffolds (Ulm 
and Krauss, 1960; Block et  al., 1977) and hydrogels (Dahms 
et al., 1997) were introduced in ureteral reconstruction, includ-
ing decellular scaffolds. Synthetic scaffolds often have a lack in 
biocompatibility, peristaltic motion, and incrustation. Decellular 
scaffolds have several advantages over other implants. They can 
be obtained easily from various species. The cellular components 
can be removed from the tissues using a broad range of methods 
(Gilbert et  al., 2006; Koch et  al., 2012), resulting in decellular 
extracellular matrix (ECM). Mostly, the structural ECM proteins 
remain intact three dimensionally, facilitating host cell ingrowth 
(Badylak, 2004; Koch et al., 2012). Furthermore, antigenic bind-
ing sites were strongly reduced due to the removal of DNA and 
other cellular components. On the other hand, inflammatory 
reactions within the tissue and degradation cannot entirely be 
excluded. Inflammatory reactions are likely to be caused by the 
ECM proteins, providing co-stimulatory signals to immune cells 
(Lider et al., 1995; Tanemura et al., 2000; Allman et al., 2001, 2002; 
Badylak, 2004; Konakci et  al., 2005; Morwood and Nicholson, 
2006; Adair-Kirk and Senior, 2008; Badylak and Gilbert, 2008; 
Koch et al., 2012). The intensity of the inflammatory reaction and 
the subsequent degradation and remodeling of decellular scaffolds 
is strongly tissue dependent and also influenced by the chemical 
treatment (Badylak, 2004; Gilbert et al., 2006; Valentin et al., 2006; 
Badylak and Gilbert, 2008; Koch et al., 2012). Though preliminary 
results with decellular matrices yielded promising results concern-
ing the ingrowth of urothelium, of smooth muscle cells (SMC) and 
nerve fibers (Dahms et al., 1997). Therefore, decellular scaffolds 
have to meet two goals. First, ECM scaffolds should maintain their 
mechanical properties, providing an adequate matrix that allows 
the cell ingrowth in vivo. Second, moderate scaffold degradation 
is necessary to allow for tissue remodeling. To meet these goals, 
chemical crosslinking agents are applied (Koch et al., 2012).
The goals of the given study were as follows: (A) to characterize 
tissue-engineered decellular porcine ureteral scaffolds and (B) to 
determine the influence of crosslinking agents on the morphologi-
cal matrix properties and cell ingrowth in vitro. Furthermore, we 
aimed (C) to investigate whether decellular ureters might provoke 
inflammatory responses or rejection reactions. Another goal of 
the given study was to evaluate a method to manufacture scaffolds 
suitable for storage by means of lyophilization.
We addressed the following hypotheses:
 1. Porcine ureters can be decellularized successfully, thus 
preserving ECM composition.
 2. Tissue-engineered decellular ureteral scaffolds can be 
reseeded with different cells in  vitro and do not provoke 
rejection reactions in vivo.
 3. Inflammatory reactions and degradation rate might be 
influenced by different crosslinking agents in vivo.
Materials and Methods
Porcine Ureteral scaffolds
All experiments were performed with ureters from pigs (Deutsche 
Landrasse, 25–65 kg). The methods used in the present study were 
similar in some aspects to those of earlier published work (Koch 
et al., 2012) and complemented by DNA- (2.2), SDS- (2.3), and 
reseeding-assays (2.6). The organs were obtained under sterile con-
ditions and were stored at 4°C in a 0.9% NaCl solution. For decel-
lularization, ureters were cut into pieces of 8 cm length. The tunica 
adventitia was removed mechanically. Ureters were then placed 
in a 1% sodium dodecyl sulfate solution (SDS; Roth, Karlsruhe, 
Germany) for 7 days. Afterwards, the scaffolds were washed in 
distilled water for 7 days, sterilized by gamma radiation (25 kGy 
from a 60Co source) and stored in PBS at 4°C for a maximum of 
4 weeks. SDS solution and distilled water were changed daily.
Dna Quantification and Qualitative  
Fragment analysis
The isolation and quantification of DNA in the decellular tissue 
scaffolds was performed using the protocol of Qiagen (DNeasyTM, 
Hilden, Germany) and as previously described (Koch et al., 2012). 
In brief, decellular ureteral scaffolds were cut into small cross-
sectional pieces of 25 mg each and proteinase K (Qiagen, in lysis 
buffer) was added. Following incubation for 12 h in a shaking water 
bath (56°C), the DNA was purified and measured spectrophoto-
metrically using a Nanodrop Spectrophotometer (Peqlab, Erlangen, 
Germany). The DNA content of matrix scaffolds undergoing 
enzymatic digestion with DNase (200 μg/ml; Sigma, Deisenhofen, 
Germany; 12 h at 37°C) was compared to the scaffolds without 
enzymatic digestion (both n = 9). Native ureters with the same 
origin served as positive control (n = 9). For qualitative fragment 
length analysis, 5–12  μg of total DNA was electrophoretically 
separated in a 1.5% agarose gel (50 min, 120 V). After the run, the 
gel was documented by light exposure in the FastGeneGelPic LED 
Bos (Nippon Genetics Europe, Dueren, Germany).
sDs assay
The determination of residual SDS was performed using an anionic 
surfactants test kit (Nanocolor®, Macherey-Nagel GmbH & Co. 
KG, Düren, Germany). Dried decellular ureteral scaffolds were cut 
into small cross-sectional pieces of 100 mg and were homogenized 
using liquid nitrogen. In addition, scaffold powder was dissolved 
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in distilled water (4 ml) and added to test tubes containing 4 ml 
chloroform and 2 ml methanol (5%). Furthermore, 0.5 ml of a 
methylene blue solution (1%) was added and mixed intensively 
for 1 min. After incubation time of 10 min, the absorption of the 
chloroform-containing phase was measured spectrophotometri-
cally at the absorption maximum of 660 nm. For the calculation 
of residual SDS concentrations within scaffold pieces before and 
after washing (n = 12), a calibration curve was prepared.
lyophilization of Ureteral scaffolds
For lyophilization, the sterilized scaffolds were placed in a plastic 
bowl filled with distilled water at room temperature. The bowls 
were immersed in a vessel filled with liquid nitrogen until distilled 
water containing the scaffolds was frozen. The frozen scaffolds were 
then placed in a freeze-dryer (Alpha 1–4 LDC-1, Martin Christ 
Gefriertrocknungsanlagen GmbH, Osterode, Germany) and scaf-
folds were lyophilized applying a constant vacuum (0.05 mbar, RZ-5, 
Vacuubrand, Wertheim, Germany) in a range from −40 to 0°C.
crosslinking of Ureteral scaffolds
Scaffold-crosslinking with different agents was performed as 
previously described (Koch et al., 2012). In brief, for genipin (GP) 
crosslinking, the scaffolds were incubated in a 0.33% GP/ethanol 
solution (Alexis, Lausen, Switzerland) for 3 days at 37°C. Then the 
scaffolds were removed and rinsed in 75% ethanol for 2 h and in PBS 
for 3 days (Sung et al., 1999b; Liang et al., 2004; Mantovani et al., 
2005; Koch et al., 2012). For carbodiimide (CDI) crosslinking cir-
cular pieces of ureter scaffolds (3 mm thickness) were immersed in 
2-(N-morpholino) ethanesulfonic acid buffer (MES buffer; 0.2 M, 
pH 5.0; Sigma, Munich, Germany). After 1 h, the MES buffer was 
discarded and the scaffolds were incubated in a solution consist-
ing of MES buffer (0.2 M, pH 5.0), N-hydroxysuccinimide (NHS; 
0.12 M), and N-(3-dimethylaminopropyl)-N-ethylcarbodiimide 
(EDC; 0.3 M). After 16 h, the scaffolds were removed and rinsed 
in MES buffer for 24 h and in PBS for at least 24 h (Cao and Xu, 
2008; Everaerts et al., 2008; Koch et al., 2012). For glutaraldehyde 
(GA) crosslinking, the scaffolds were immersed in 0.625% glutar-
aldehyde/distilled water (Sigma) for 3 days at 37°C. Subsequently, 
the scaffolds were removed and washed in PBS for 3 days (Chang 
et al., 2005; Koch et al., 2012).
reseeding Decellular Ureteral scaffolds
Sterilized decellular scaffold pieces of 1  cm, which were either 
crosslinked, chemically untreated or lyophilized were placed in 
tubes (15  ml, BD Falcon®, Becton, Dickinson and Company, 
Heidelberg, Germany) containing different cell lines (Caco2, LS48, 
3T3) or native rat SMC. Scaffolds and cells were incubated (each 
1.5–2.0 × 106 cells/tube) on a rotator (Multi-RS 60, Biosan, Riga, 
Latvia) at room temperature for 4 h. Afterwards, scaffolds were 
placed in well plates and incubated under constant conditions 
(37°C, 5% CO2) for 2 weeks (n = 7–9). After incubation, scaffold 
pieces were fixed in 4% paraformaldehyde solution and embedded 
in paraffin for further histological investigations.
subcutaneous rat Model
110 Sprague-Dawley rats were grouped according to scaffold 
crosslinking: GA, GP, CDI, BP, untreated group, and sham 
group (each treatment group: n = 18; sham group: n = 20; for 
more details please refer to Table 1). One scaffold was implanted 
subcutaneously into each of the individuals of the respective 
groups. Animals of the sham group underwent the same surgical 
procedure but received no implant. The subcutaneous implanta-
tion of scaffold pieces was performed as previously described 
(Koch et  al., 2012). In brief, animals were anesthetized with 
5% isoflurane (Baxter Deutschland GmbH, Unterschleissheim, 
Germany) in a N2/O2 gas mixture. After anesthetization, the 
concentration of isoflurane was reduced to 2% isoflurane in a N2/
O2 gas mixture to maintain anesthesia. Circular pieces of ureteral 
scaffolds (3 mm thickness, 1 cm diameter) were implanted into 
one of the subcutaneous back pockets of rats (1 cm length). The 
wound was sewn with two stitches. Finally, the concentration of 
isoflurane was reduced to allow rats to recover from anesthesia. All 
surgical interventions were performed under sterile conditions. 
Postoperatively, rats were given carprofen (5 mg/kg s.c., Pfizer, 
Berlin, Germany) for 3 days. After a follow-up of one, nine, or 
30 days, the animals were again narcotized, euthanized, and the 
scaffolds were explanted for further histological investigation. 
Therefore, the scaffolds were immersed in 4% paraformaldehyde 
solution and embedded in paraffin. All procedures were approved 
by the committee of Animal Care and Use of the relevant local 
governmental body (TVV15/10) in accordance with the Animal 
Welfare Act. Every effort was made to minimize the number of 
animals used.
histology
Following decellularization and explantation at days 1, 9, and 30 
post implantation, the scaffolds were fixed in paraformaldehyde 
solution. Representative areas were embedded in paraffin wax, 
cut into slices (5  μm thickness), and routinely stained with 
Hematoxylin–Eosin and Azan (Boldt et  al., 2006; Koch et  al., 
2012). Using these slices, matrix morphology of decellular por-
cine scaffolds was compared to that of native ureters using light 
microscopy. Furthermore, the degree of scaffold infiltration by 
giant cells, granulocytes, capillaries, collagen fibers, lymphocytes, 
and fibroblasts at days 1, 9, and 30 post implantation was analyzed 
using these slices.
Table 1 | group composition with type and crosslinking of scaffolds.
group n Type of scaffold scaffold 
crosslinking
Untreated 18 Decellularized, sterilized 
ureter scaffold
Untreated
GA 18 Decellularized, sterilized 
ureter scaffold
Glutaraldehyde
GP 18 Decellularized, sterilized 
ureter scaffold
Geripin
CDI 18 Decellularized, sterilized 
ureter scaffold
Carbodiimide
BP (control) 18 Decellularized, sterilized 
bovine pericard scaffold
Glutaraldehyde 
(bovine pericardium; 
St. Jude, USA)
Sham (negative 
control)
20 – –
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immunohistochemistry
Immunohistochemical analysis of decellular ureters was 
performed as previously described (Koch et al., 2012). Briefly, 
formalin-fixed, paraffin-embedded ureteral tissue sections of 
5  μm thickness were deparaffinized. Subsequently, the slices 
were heated in 50 mM Tris buffered saline solution at 95°C for 
15 min. After cooling, the slides were incubated with protein-
ase K (250  μg/ml) for 10  min and washed in distilled water. 
Endogenous enzyme activity was blocked (10  min, DAKO 
staining kit; DAKO Deutschland GmbH, Hamburg, Germany) 
and the tissue slides were incubated with primary antibodies. The 
staining steps with anti-collagen I (Acris Antibodies, Herford, 
Germany), anti-collagen  III (Acris Antibodies), anti-collagen 
IV (Acris Antibodies), anti-elastin (Acris Antibodies), and anti-
fibronectin (Dianova, Berlin, Germany) were performed follow-
ing the manufacturer’s instruction (Envision DAB Staining Kit, 
DAKO). Control experiments were carried out without primary 
antibodies. All antibodies were diluted 1:100 in PBS. In the stained 
slices, the ECM composition of decellular and native scaffolds 
was investigated under light microscopy. To investigate cellular 
infiltration in explanted scaffolds of the rat model, anti-CD68 and 
anti-CD163 (all Serotec, Oxford, UK) antibodies were used. All 
antibodies were diluted 1:50 in PBS. Control experiments were 
carried out without primary antibodies. To visualize the nuclei, 
all slices were counterstained with Mayer’s hemalaun solution. 
In stained slices, from each section the CD68 and CD163 posi-
tive cells as well as their nuclei were counted from each section 
in 5 × 6 random microscopic fields by two observers, blinded 
to the origin of the tissue and each other’s ratings (magnifica-
tion × 1000). The data are represented as a ratio of CD-positive 
cells/nuclei [mean value ± (SEM)]. To investigate the degradation 
of the collagen in the scaffolds, metallopeptidase 3 (MMP3) and 
the metallopeptidase inhibitor 1 (TIMP1) levels were analyzed, 
using the respective antibodies: anti-MMP3 and anti-TIMP1 
(Bioss Inc., Woburn, MA, USA). All antibodies were diluted 1:100 
in PBS. Control experiments were carried out without primary 
antibodies.
statistics
The Shapiro–Wilk test was used to determine normal distri-
bution of the data, except immunohistochemistry data. The 
statistical evaluation of the immunohistochemistry including 
CD68 + or CD163 + cells was performed using Kruskal–Wallis 
one-way analysis of variance (ANOVA) on ranks with post hoc 
Tukey test. Statistical evaluation of the reseeding procedure, the 
effectiveness of the washing of the decellular scaffolds on residual 
SDS and the respective DNA concentration was performed 
with the one-way repeated measures (RM) ANOVA on ranks 
with post hoc Tukey test. P-values of P < 0.05 were considered 
statistically significant.
results
Porcine Ureteral scaffolds
After decellularization, the ECM composition is similar to native 
ureteral tissue. Azan staining of natural (Figure 1A) and decel-
lular ureteral scaffolds (Figure  1B) revealed morphologically 
intact structures, ideal matrix geometry, and no remaining 
cellular structures. Histological analysis after lyophilization also 
showed preserved morphological structures and matrix geometry 
(Figure 1C) similar to the native and decellular conditions. After 
decellularization, collagen I (Figure 2A), collagen III (Figure 2B), 
and fibronectin (Figure 2C) could be observed in large amounts 
in all tissue areas similar to native conditions (small pictures, 
Figures 2A–C). The vessels expressed collagen IV (Figure 2D) and 
elastin, which are also located in tunica muscularis (Figure 2E).
FigUre 1 | Tissue morphology of native (a) and decellularized  
(b) porcine ureter. Decellular ureteral scaffolds showed anatomically intact 
structures, ideal matrix geometry, and no remaining cellular structures. 
Lyophilization of decellular ureters showed no effects on anatomical 
structures (c). Muscle cells, erythrocytes, and chromatin were stained red, 
connective tissue blue. Tadv, Tunica adventitia; Tmus, Tunica muscularis; 
Tmuc, Tunica mucosa. Bar = 100 μm.
FigUre 2 | immunohistochemical Dab-staining of decellular porcine 
ureteral scaffolds for collagen i (a), collagen iii (b), fibronectin (c), 
collagen iV (D), and elastin (e) in comparison to natural tissue  
(small pictures). Decellular ureteral scaffolds were shown to maintain 
native extracellular matrix composition. The arrows mark vessels.  
Bar = 100 μm.
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Dna Quantification
The analysis of the DNA content revealed significant differ-
ences among native ureters, decellular ureters, and decel-
lular ureters +  DNA digestion [P <  0.001; each n =  9]. The 
DNA content in decellular scaffolds was significantly lower 
(85.01 ± 3.1% = 966.1 ± 188.2 ng/mg tissue; P < 0.001) compared 
to that in native ureter samples (100% =  6,468.11 ±  646.9  ng/
mg tissue). An additional DNA digestion further reduced the 
amount of the DNA to 97.32 ± 0.7% (173.28 ± 36.6 ng/mg tis-
sue) compared to native ureter samples (P < 0.001; Figure 3A. 
Differences between decellular scaffolds and decellular scaffolds+ 
DNA digestion did not reach a level of significance (P = 0.31). 
The percentage of remaining DNA after both procedures was 
decreased by about 91.2% compared with native ureteral tissue 
(P <  0.001). Qualitative analysis by gel electrophoresis showed 
intact DNA bands in the native samples with a size larger than 
3,000 base pairs. Decellularization caused a gross but incomplete 
removal of this band, accompanied by a visible DNA-smear. When 
treating the decellular scaffolds with DNase, the smear was grossly 
removed (Figure 3B).
residual sDs
A significant effect of the washing duration on the SDS-
concentration was observed, resulting in a 99.93% decrease, 
FigUre 3 | (a) Shows the comparison of remnant DNA in decellular ureteral 
tissue with and without DNA digestion (both n = 9). Significant differences 
between both groups were not found. Native, untreated ureteral tissue 
served as control (n = 9). In (b), gel electrophoresis of native ureter sample 
(2) and corresponding decellular scaffold without (3) and with DNase (4) is 
shown. Lane numbers indicate the respective sample. (c) shows the 
analysis of residual SDS before and after washing in distilled water (n = 12). 
Decellular ureteral scaffolds showed high SDS-concentrations 
(8.45 ± 0.43 mg/g dry tissue) before washing compared to non-toxic 
SDS-concentration after washing with distilled water (0.01 ± 0.01 mg/g dry 
tissue). Washed scaffold pieces show residual SDS-concentrations of 
0.07 ± 0.05% compared to scaffolds before washing (P < 0.001; not 
shown). ***P < 0.001 vs. native group. +++P < 0.001 vs. decellular ureteral 
scaffolds before washing.
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compared to residual SDS before washing. The concentration 
of SDS within the scaffolds after washing in distilled water was 
0.006 ± 0.01 mg/g dry tissue vs. 8.449 ± 0.43 mg/g dry tissue in 
scaffolds before washing ([F(1,11) = 391.89, P < 0.001], each n = 12, 
Figure 3C).
reseeding Decellular Ureteral scaffolds
After incubation for 2 weeks, the ureteral scaffolds were increas-
ingly infiltrated by tested cell lines (Figures 4 and 5). LS48 cells 
were uniformly distributed at the scaffold surface (Figures 5A–D). 
No significant effects of crosslinking were observed on cell growth 
(Figure 4A). 3T3 cells showed a higher infiltration after crosslink-
ing with CDI or GP ([F(3,24) = 6.84, P = 0.002]; CDI: P < 0.05, 
GP: P = 0.001; Figure 4B). Furthermore, multilayer formation 
(GA, CDI, GP) and moderate scaffold infiltration (CDI, GP) were 
detected in crosslinked scaffolds, whereas only sporadic cells could 
be detected in the untreated scaffold group (Figures 5E–H). After 
incubation with Caco2 cells, the relative amount of cells did not 
differ between any of the groups (Figure 4C). However, scaffold 
infiltration and multilayer formation were predominant after 
crosslinking with GP or CDI (Figures 6A–D). Furthermore, SMC 
showed a preference for crosslinked scaffolds (Figures  6E–H), 
whereas the highest infiltration was observed after crosslinking 
with GP ([F(3,18) = 5.32, P < 0.008]; P < 0.01; Figure 4D). However, 
reseeding of lyophilized scaffolds failed; neither cell lines nor native 
cells were grown on dried scaffolds (data not shown). Interestingly, 
lyophilized implants were degraded by cell lines within 2 weeks.
response to implanted Decellular Ureteral 
scaffolds
The cell infiltration in untreated (Figures 7A,C,E) and crosslinked 
scaffolds (Figures  7B,D,F) was analyzed histologically after 
FigUre 4 | reseeding of crosslinked or chemical untreated 
ureteral scaffolds with ls48 (a), 3T3 (b), aco2 (c), and smooth 
muscle cells (D). Cells are able to grow on chemically untreated and 
crosslinked scaffolds after incubation for 2 weeks. Effects of crosslinking 
on relative amount of cells could not be detected under seeding with 
LS48 [(a), n = 9] and Caco2 [(c), n = 9] cells. However, 3T3 cells show 
an increased infiltrating rate into CDI and GP crosslinked scaffolds, 
compared to the untreated group [(b), n = 9]. Furthermore, crosslinking 
with GP caused an increase of smooth muscle cells, grown on surface 
and infiltrate scaffolds [(D), n = 7]. Data were calculated based on the 
scoring by two blinded observers: 1 = no cells; 2 = in total <20 cells; 
3 = partially 1 cell layer, in total <50 cells, 4 = 1 cell layer around the 
scaffold; 5 = cells are arranged in multilayer, with matrix-infiltration. 
Untreated, untreated decellular ureteral tissue; GP, genipin; GA, 
glutaraldehyde; CDI, carbodiimide. *P < 0.05, **P < 0.01, ***P < 0.001 
vs. decellular ureteral scaffolds.
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explantation at days 1, 9, and 30 post implantation. At day 1 after 
implantation, a cellular infiltration directed from the periphery 
to the center of the respective tissue was observed in untreated 
scaffolds (Figure 7A). After crosslinking with CDI (Figure 7B), 
a cellular layer was detectable at the periphery and only a few 
number of cells infiltrated the central parts of the scaffolds. At day 
9 post implantation, a decrease of cell infiltration was observed in 
crosslinked scaffolds (Figure 7D) compared to that in untreated 
scaffolds (Figure 7C). At day 30 post implantation, the untreated 
implants were largely degraded and completely infiltrated with 
cells (Figure 7E). In the CDI crosslinked group only an immaterial 
cellular infiltration could be detected (Figure 7F). In all crosslinked 
groups (GP, GA, CDI, BP), the cell infiltration was lower compared 
to the untreated scaffold group but without significant differences 
among the groups.
Only the GA crosslinked group showed a significant increase of 
giant cells compared to untreated group at day 9 post implantation 
(Figure 8A, P < 0.01). At day 1 post implantation, granulocytes 
were present in each group. Their number decreased and dimin-
ished toward day 30 post implantation in most groups, excepting 
the untreated and BP group (Figure  8B). Neovascularization 
(Figure  8C), new collagen fibers (Figure  8D), and fibroblasts 
(Figure  8F) were present in all groups without significant dif-
ferences. At day 1 after implantation, lymphocytes were present 
in each group and did not differ to day 9 or 30 post-operative 
(Figure 8E).
At day 1 after implantation, MMP3 was activated in all groups 
(untreated: Figure 9A, crosslinked: Figure 9B) and increased to 
day 9 (untreated: Figure 10A, crosslinked: Figure 10B), whereas 
the reactivity was weaker in crosslinked than in untreated scaffolds. 
At day 30, MMP3 was detectable in both untreated (Figure 11A) 
and crosslinked (Figure  11B) scaffolds with same intensity. 
Scaffolds of all groups were negative for TIMP1 at all time-points 
(Figures 9C,D; Figures 10C,D; Figures 11C,D).
A detailed macrophage analysis showed only a few number of 
CD163 positive cells at the periphery of BP and CDI crosslinked 
samples at day 1 after implantation. Furthermore, the number 
of CD68 positive cells was higher in the BP group compared to 
that in untreated scaffolds ([F(4,25) = 9.80, P < 0.001]; P < 0.001, 
Figure 12A). Scaffold analysis at day 9 after implantation revealed a 
significant increase of CD68 positive macrophages after crosslink-
ing with GA compared to the untreated group ([F(4,25) =  4.40, 
P = 0.008]; P < 0.05). At day 30 post-operative, there were no 
significant effects of crosslinking on the number of CD68 and 
CD163 positive cells (Figure 12B). Additionally, in most groups, 
the amount of the anti-inflammatory, pro-remodeling macrophage 
M2 phenotype increased from day 9 to day 30, indicated by a 
positive CD163/CD68 ratio (untreated: +10.05%; BP: +65.37%; 
CDI + 114.03%), whereas it decreased in the GP (−28.31%) and 
GA (−58.48%) groups (Figure 12C).
Discussion
Different surgical techniques were employed for ureter reconstruc-
tion such as Boari flap, psoas hitch, downward mobilization of 
the kidney, and replacement with ileal or bladder tissue. These 
FigUre 5 | reseeding of crosslinked or chemical untreated 
ureteral scaffolds with ls48 and 3T3 cells. LS48 cells grew 
sporadically on scaffolds and showed small clusters. However, 
crosslinking showed no effect on capability of cells to grow on scaffolds 
(a–D). Furthermore, 3T3 cells prefer crosslinked scaffolds (e–h). 
Multilayer formations and infiltration was predominant in CDI (F) and GP 
(h) crosslinked scaffolds, whereas only few cells were detectable in 
untreated scaffold group.
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reconstructing techniques are accompanied by several complica-
tions (i.e., excessive formation of mucus, ureteral stenosis, infec-
tion, renal, chronic renal failure, and metabolic disturbances or 
urolithiasis) (Corvin et al., 2004; Schlote et al., 2004; Wolff et al., 
2011). Therefore, the development of a biocompatible ureteral 
implant would be of high clinical interest. Different types of scaffold 
materials such as hydrogels, synthetic, or natural scaffolds have 
already been studied in tissue engineering (Dahms et al., 1997). 
Partial or total ureteral replacement by synthetic materials such 
as teflon (Ulm and Krauss, 1960) or dacron (Block et al., 1977) 
FigUre 6 | reseeding of crosslinked or chemically untreated ureteral 
scaffolds with caco2 and rat smooth muscle cells. Only a low rate of 
Caco2 cells was detectable in untreated (a) and GA crosslinked (c) scaffolds. 
After CDI (b) and GP (D) crosslinking, Caco2 cells showed multilayer formation 
and scaffold infiltration. Smooth muscle cells also preferred crosslinked 
scaffolds (e–h), whereas cell-cluster and infiltration were observed. Untreated, 
untreated decellular ureteral tissue; GP, genipin; GA, glutaraldehyde; CDI, 
carbodiimide. Bar = 100 μm.
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was examined. Unfortunately, these materials showed a lack of 
biocompatibility, peristalsis, and moderate incrustation. Biological 
ECM scaffolds possess intact structural proteins and growth factors 
that reduce inflammatory responses (Badylak, 2004; Chang et al., 
2005; Badylak and Gilbert, 2008). Nevertheless, decellular scaf-
folds have several advantages over synthetic implants. The scaffold 
materials can be easily obtained from different species. The cellular 
components can be removed from the tissue/organ by a broad 
range of various methods (Gilbert et al., 2006; Koch et al., 2012), 
resulting in decellular ECM. Structural proteins of the ECM remain 
intact and ECM scaffolds have a three-dimensional structure that 
facilitates host cell ingrowth (Badylak, 2004; Koch et al., 2012). 
FigUre 7 | histological analysis of he-stained subcutaneous implanted 
untreated (a,c,e) and cDi crosslinked scaffolds (b,D,F) explanted at 
days 1, 9, and 30 post-operative. At day 1 post implantation, cellular 
infiltration with granulocytes, fibroblasts, and macrophages could be observed 
in untreated scaffolds (a), whereas in CDI crosslinked scaffolds (b) only a 
cellular layer was detectable at the periphery. At day 9 post implantation, a 
notable increase of infiltrating cells into untreated scaffolds (c) was detected as 
a sign of encapsulation. CDI crosslinked (D) scaffolds showed a mild cellular 
infiltration with granulocytes, fibroblasts, and macrophages. At day 30 post 
implantation, in contrast to the untreated scaffold group (e), CDI crosslinked 
scaffolds (F) showed only a marginal cellular infiltration by granulocytes, 
fibroblasts, and macrophages. Untreated scaffolds were completely infiltrated 
by cells and largely degraded. Detailed cellular analysis is displayed in 
Figure 8. Bar = 100 μm.
June 2015 | Volume 3 | Article 8910
Koch et al. Crosslinking of ureteral scaffolds
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org
Due to removing the DNA and cellular components, the antigenic 
binding sites were strongly reduced. Therefore, one might assume 
that decellular scaffolds do not provoke a chronic rejection reac-
tion after implantation, even if originating from another species. 
In 1997, first preliminary experiments with decellular matrixes 
showed promising results concerning the ingrowth of urothelium, 
SMC and nerve cells (Dahms et al., 1997). However, complications 
such as ureteral occlusion and finally hydronephrosis were also 
described (Sofer et al., 2002). In addition, previously published data 
suggest that the host response to the ECM scaffolds was strongly 
dependent on the species and chemical pre-treatment (Sung et al., 
1999a,b; Chang et al., 2002, 2005; Liang et al., 2004; Badylak and 
Gilbert, 2008; Cao and Xu, 2008; Everaerts et al., 2008; Koch et al., 
2012). Therefore, currently published data are not universally 
consistent. Thus, it was first essential to test the morphological 
characteristics and the biocompatibility of the ureteral scaffolds.
To the best of our knowledge, we are the first to describe the 
decellularization of porcine ureters and investigated the influence 
of different crosslinking agents on cellular reseeding in vitro and 
on the inflammatory response in vivo in one study.
Ureter Decellularization and Matrix composition
According to our hypothesis, porcine ureters can be easily decel-
lularized. After decellularization, histological analysis revealed 
morphological intact structures, optimal matrix geometry and no 
remaining cellular structures. Lyophilized ureters showed intact 
morphological structures, whereas collagen I, III, IV, fibronectin, 
and elastin could be observed in amounts similar to natural or 
decellular ureters.
success of In Vitro reseeding Depends on 
crosslinker
In vitro data showed a considerable ingrowth of different cell lines 
(LS48, 3T3, Caco2) and SMC), depending on crosslinking. Highest 
infiltration was offered by the crosslinkers CDI and GP compared 
to other crosslinkers and chemically untreated scaffolds. These 
findings reflect not only the positive effects of crosslinking but also 
the effectiveness of washing out residual cytotoxic SDS concentra-
tions (remove of 99.93% SDS). In contrast to crosslinking with GP 
or CDI, the infiltration of cells into GA crosslinked scaffolds was 
comparable to untreated scaffolds in vitro as a sign of non-optimal 
FigUre 8 | histological analysis of the degree of scaffold infiltration by 
giant cells (a), granulocytes (b), capillaries (c), collagen fibers (D), 
lymphocytes (e), and fibroblasts (F) at days 1, 9, and 30 post 
implantation. In all implants, an increase of infiltrating giant cells, lymphocytes, 
fibroblasts, capillaries, and collagen fibers could be detected over time. 
Furthermore, a decrease of infiltration by granulocytes could be observed in all 
implants at day 30 compared to day 1 post implantation. A blinded pathologist 
evaluated the presence of cells (granulocytes, lymphocytes, giant cells, and 
fibroblasts), capillaries and new collagen fibers and generated a 
semiquantitative score in repeat determination (0 = negative, 1 = mild, 
2 = moderate, 3 = serve; n = 6/group and day; five microscopic fields per slide 
and rat; each 5 mm2). Untreated, untreated decellular ureteral tissue; BP, 
bovine pericardium (St. Jude, USA); GP, genipin; GA, glutaraldehyde; CDI, 
carbodiimide. **P < 0.01 vs. untreated decellular ureteral tissue.
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growth conditions. After GP crosslink, an increase of ingrown cells 
was described compared to GA crosslink (Sung et al., 1999b; Koch 
et al., 2012), whereas signs of calcification were not detected in GP 
fixed tissue (Sung et al., 1999a). In the present study, we found a 
significantly increased ingrowth and multilayer formation of 3T3 
and SMC after GP crosslinking compared to that in untreated 
scaffolds in  vitro. In comparison to untreated scaffolds, CDI 
crosslinked scaffolds showed an increase of infiltrating 3T3-cells 
and multilayer formation as a sign of optimal environment compa-
rable to GP-treated group. In contrast to recent studies, cells did not 
grow on lyophilized ureters (Kim et al., 2012; Woon et al., 2012); 
this might indicate that molecular characteristics were changed 
during lyophilization. On the basis of the facts, lyophilization could 
not be an optimal alternative to store ureteral scaffolds at this time. 
However, it would be relevant to analyze molecular changes after 
lyophilization of crosslinked scaffolds in further studies.
inflammation, Tissue resorption and 
remodeling Processes Depend on  
crosslinker In Vivo
In addition, it is fundamental to determine the host response 
after subcutaneous implantation of different crosslinked ureteral 
scaffolds. Since the scaffolds were decellular and morphologically 
intact, we could show in a subcutaneous rat model with decel-
lular esophagus scaffolds that chronic rejection will not occur 
and implants are well tolerated (Koch et al., 2012). The present 
work supplements the biocompatible characteristics of acellular 
scaffolds by reseeding experiments, DNA analysis, and an SDS 
assay. At days 9 and 30 post implantation, signs of inflammation 
such as encapsulation and scaffold infiltration by macrophages 
and fibroblasts were observed and consistent with our expecta-
tions. We do not assume that DNA remnants of the scaffolds 
were the cause of inflammatory reactions in our experiments. 
FigUre 10 | immunohistochemical Dab-staining of decellular cDi 
crosslinked implants for MMP3 and TiMP1 in comparison to chemical 
untreated scaffolds after 1, 9, and 30 days in vivo (n = 6/day/group). 
Nine days post-implantation, the rate of MMP3 [untreated: (a), CDI: (b)] 
reactivity increased compared to post-operative day 1. TIMP1 reactivity could 
not be detected in both untreated (c) and crosslinked (D) scaffolds.
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After DNA extraction, we could not detect large remnant DNA 
fragments. Furthermore, we could show a reduction in remnant 
DNA of 91.2% compared to that of native ureters. In most biologi-
cal material, remaining DNA consisted of fragments <300 bp, 
whereas DNA in our experiments almost disappeared. The small 
amount of remnant DNA is subject to fast enzymatic degradation 
in vivo (Badylak and Gilbert, 2008). It is more plausible, that free 
amino (–NH2), carboxyl (–COOH) and hydroxyl (–OH) groups 
of collagen may be responsible for the immunological reactions 
(Sung et al., 1999b; Liang et al., 2004; Chang et al., 2005; Cao and 
Xu, 2008; Koch et al., 2012). These free groups can be bound by 
chemical crosslinking, which prevents the development of anti-
genic properties (Ye et al., 1996; Khor, 1997). Another side effect 
of crosslinking is an increase in mechanical stability. However, 
some crosslinking agents (e.g., GA) are toxic or promote the 
calcification of scaffolds in vivo (Khor, 1997; Sung et al., 1999a; 
Chang et al., 2002; Everaerts et al., 2008; Koch et al., 2012). In the 
present study, the crosslinkers GA, GP, and CDI were selected in 
accordance with descriptions of the biocompatibility in the recent 
literature (Khor, 1997; Sung et al., 1999b; Liang et al., 2004; Chang 
et al., 2005; Cao and Xu, 2008; Koch et al., 2012; Jeong et al., 2013).
Glutaraldehyde is an aggressive, indiscriminant crosslinking 
reagent that is commonly used in commercially available tissues 
(Badylak and Gilbert, 2008). GA crosslinked tissue exhibits a 
stabilized collagen matrix and decreased immunological reaction 
(Jeong et al., 2013; Awang et al., 2014). However, we observed that 
the immunological response (giant cells, CD68+ macrophages) 
in GA crosslinked ureteral scaffolds was higher compared to that 
FigUre 9 | immunohistochemical Dab-staining of decellular cDi 
crosslinked implants for MMP3 and TiMP1 in comparison to 
chemical untreated scaffolds after 1, 9, and 30 days in vivo (n = 6/
day/group). One day post implantation, MMP3 were detectable in both 
untreated (a) and CDI crosslinked (b) scaffolds, whereas CDI 
crosslinked scaffolds showed a weaker intensity. However,  
scaffolds of both groups were negative for TIMP1 [untreated:  
(c), CDI: (D)]. 
FigUre 11 | immunohistochemical Dab-staining of decellular cDi 
crosslinked implants for MMP3 and TiMP1 in comparison to chemical 
untreated scaffolds after 1, 9, and 30 days in vivo (n = 6/day/group).  
At day 30 post implantation, MMP3 could be detected in both groups 
[untreated: (a), CDI: (b)], whereas TIMP1 was not detectable in both untreated 
(c) and CDI crosslinked (D) scaffolds. Bar = 100 μm.
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After DNA extraction, we could not detect large remnant DNA 
fragments. Furthermore, we could show a reduction in remnant 
DNA of 91.2% compared to that of native ureters. In most biologi-
cal material, remaining DNA consisted of fragments <300 bp, 
whereas DNA in our experiments almost disappeared. The small 
amount of remnant DNA is subject to fast enzymatic degradation 
in vivo (Badylak and Gilbert, 2008). It is more plausible, that free 
amino (–NH2), carboxyl (–COOH) and hydroxyl (–OH) groups 
of collagen may be responsible for the immunological reactions 
(Sung et al., 1999b; Liang et al., 2004; Chang et al., 2005; Cao and 
Xu, 2008; Koch et al., 2012). These free groups can be bound by 
chemical crosslinking, which prevents the development of anti-
genic properties (Ye et al., 1996; Khor, 1997). Another side effect 
of crosslinking is an increase in mechanical stability. However, 
some crosslinking agents (e.g., GA) are toxic or promote the 
calcification of scaffolds in vivo (Khor, 1997; Sung et al., 1999a; 
Chang et al., 2002; Everaerts et al., 2008; Koch et al., 2012). In the 
present study, the crosslinkers GA, GP, and CDI were selected in 
accordance with descriptions of the biocompatibility in the recent 
literature (Khor, 1997; Sung et al., 1999b; Liang et al., 2004; Chang 
et al., 2005; Cao and Xu, 2008; Koch et al., 2012; Jeong et al., 2013).
Glutaraldehyde is an aggressive, indiscriminant crosslinking 
reagent that is commonly used in commercially available tissues 
(Badylak and Gilbert, 2008). GA crosslinked tissue exhibits a 
stabilized collagen matrix and decreased immunological reaction 
(Jeong et al., 2013; Awang et al., 2014). However, we observed that 
the immunological response (giant cells, CD68+ macrophages) 
in GA crosslinked ureteral scaffolds was higher compared to that 
FigUre 9 | immunohistochemical Dab-staining of decellular cDi 
crosslinked implants for MMP3 and TiMP1 in comparison to 
chemical untreated scaffolds after 1, 9, and 30 days in vivo (n = 6/
day/group). One day post implantation, MMP3 were detectable in both 
untreated (a) and CDI crosslinked (b) scaffolds, whereas CDI 
crosslinked scaffolds showed a weaker intensity. However,  
scaffolds of both groups were negative for TIMP1 [untreated:  
(c), CDI: (D)]. 
in chemically untreated scaffolds. Furthermore, the polariza-
tion of macrophages is important to the remodeling outcome. 
M1-activated macrophages produce inflammatory cytokines, 
which promote active inflammation and were associated with 
rejection reactions. In contrast, M2-activated macrophages 
(CD163+) are able to facilitate tissue repair and constructive 
remodeling (Mantovani et  al., 2005; Brown et  al., 2009; Chin 
et al., 2011). Macrophages are able to change their polarization 
in response to local stimuli during the process of wound healing 
(Mantovani et al., 2004; Stout and Suttles, 2005; Martinez et al., 
2008; Kushiyama et al., 2011). The recognition of the predominant 
phenotype of macrophages provides an indication of scaffold rejec-
tion, inflammation, or acceptance after implantation. Interestingly, 
in contrast to the untreated, BP, and CDI groups, the CD163/
CD68 ratio was decreased after GA treatment at day 30 post 
implantation. This might indicate a switch to a pro-inflammatory 
and destructive M1 macrophage phenotype after GA treatment. 
Furthermore, cellular toxicity and cytotoxic T-cell activation have 
been described after incomplete suppression of immunological 
actions of GA crosslinked scaffolds (Nishi et al., 1995; Chang et al., 
2002; Kim et al., 2014; Manickam et al., 2014). On the other hand, 
cytotoxic effects of GA crosslinked scaffolds for host cells (fibro-
cytes, fibroblasts, and macrophages) were described (Huang et al., 
1998). We did not observe any cytotoxic effect of GA crosslinked 
ureteral scaffolds on host fibroblasts or macrophages in vivo. In 
addition, further disadvantages of GA (e.g., scaffold calcification 
and depolymerization of GA crosslinks) have been reported (Khor, 
1997; Schoen and Levy, 2005; Liu et al., 2014). The data suggest that 
FigUre 12 | immunohistochemical analysis of the degree of scaffold 
infiltration by cD68 + (a) and cD163 + (b) macrophages after 1, 9, 
and 30 days, as well as the change of the cD163/cD68 ratio from day 
9 to day 30 (c). An increase of CD68 + and CD163 + macrophages could 
be observed in all groups from day 1 to day 9, whereas the amount remains 
constant to day 30 post implantation. In addition to the standard group, 
untreated and CDI-crosslinked scaffolds showed a macrophage M2 
phenotype switch, indicated by a positive CD163/CD68 ratio at day 30 
compared to ratio at day 9. All data were represented as ratios of specific 
cells/total cells ± SEM. Five microscopic fields (magnification × 000) of one 
slide per rat were analyzed (n = 6/group and day). An average of 54 ± 1.59 
total cells per microscopic field was counted to generate the ratio of cells/
total cells. Untreated, untreated scaffold; BP, bovine pericardium (St. Jude, 
USA); GP, genipin; GA, glutaraldehyde; CDI, carbodiimide. *P < 0.05, 
**P < 0.01 vs. untreated decellular ureteral tissue.
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GA was not an optimal crosslinker for constructive remodeling in 
the present study (e.g., giant cell and CD68 + macrophage infiltra-
tion in vivo, poor biocompatibility in vitro), which corresponds 
with other disadvantages described in the literature (Nishi et al., 
1995; Huang et al., 1998; Koch et al., 2012).
Genipin has been widely used as a natural crosslinker as a substi-
tute for chemical crosslinkers. It reacts with collagen amino groups 
and is approximately 10,000 times less cytotoxic than GA (Sung 
et al., 1999b). The stable GP crosslinked products protect against 
inflammation, degradation, react antiphlogistically and resulted in 
faster tissue regeneration compared to GA (Liang et al., 2004; Koo 
et al., 2006; Li et al., 2012). Furthermore, a significantly decreased 
inflammatory response compared to untreated and GA crosslinked 
scaffolds is described after implantation of GP and GA crosslinked 
decellular bovine pericardia (Chang et al., 2002). However, in our 
subcutaneous rat model, we could show that macrophages were 
present in all scaffolds (untreated and crosslinked) at days 1, 9, 
and 30 post implantation. In contrast to previous studies (Koch 
et al., 2012), we also detected a M1 macrophage phenotype switch 
after GP crosslinking comparable to the GA group, indicating pro-
inflammatory and destructive processes. In this way, our data suggest 
that GP was not the optimal crosslinker for constructive remodeling.
The alternative crosslinker, CDI, activates carboxyl groups for 
spontaneous reaction with primary amines of aspartic acid and 
glutamic acid residues of collagen, generating the crosslink (Khor, 
1997). Furthermore, recent literature showed that tissue quality 
was improved, calcification was decreased and tissues offered a 
good biocompatibility (Khor, 1997). Based on these facts, it is not 
remarkable that CDI was also used in commercially available tissue 
products (Badylak and Gilbert, 2008). However, it was reported 
that CDI crosslinking caused a decrease in elasticity and mechani-
cal toughness (Rafat et al., 2008). In this study, we did not analyze 
the mechanical properties, but we observed that CDI and GP 
fixed scaffolds exhibited only a moderate degradation. However, 
a predominant M1 macrophage phenotype was observed after 
implantation of CDI crosslinked esophagus scaffolds in a recent 
study (Koch et al., 2012). Interestingly, we detected a remarkable 
M2 macrophage phenotype switch after CDI crosslinking in vivo, 
which is known to be associated with constructive remodeling and 
tissue repair (Khor, 1997; Chang et al., 2002; Koch et al., 2012). 
Furthermore, the presence of pro-remodeling macrophages and 
fibroblasts might suggest host repair and constructive remodeling 
(Chin et  al., 2011). Furthermore, the infiltration, survival, and 
living of the tissue-fibroblasts support the good biocompatibility 
of CDI scaffolds in vivo.
In addition, the activation of MMP3 and the inactivation 
of TIMP1 indicate remodeling and healthy processes and were 
also analyzed at each point of time. MMP3 degrades fibronectin, 
laminin, elastin, collagen (II, IV, IX, X, XI), and activates col-
lagenase1 (Bullard et  al., 1999; Shantha Kumara et  al., 2014). 
MMP3 was synthesized by fibroblasts, activated macrophages 
and keratinocytes adjacent to sites of injury and was found in 
settings where active ECM remodeling occurs (Bullard et al., 1999). 
Furthermore, MMP3 can also activate other MMPs such as MMP1, 
MMP7, and MMP9, rendering MMP3 crucial in connective tissue 
remodeling (Ye et al., 1996). The enzyme is not only considered to be 
involved in wound repair but also in progression of atherosclerosis 
and tumor initiation (Shantha Kumara et al., 2014). In the present 
study, MMP3 was detectable in each group, whereas reactivity was 
decreased after crosslinking compared to untreated scaffolds, as 
a sign of increased stability, required for adequate constructive 
remodeling processes. The MMP3 reactivity after crosslinking 
(GA, GP, CDI) reached its maximum in the CDI group, at day 30 
post-operative. TIMP1, a tissue inhibitor of metalloproteinases, is 
a glycoprotein that is expressed from several tissues of organisms, 
able to promote cell proliferation in a wide range of cell types, 
and might also have an anti-apoptotic function. In the present 
study, TIMP1 was not detected at any point in time.
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conclusion
We reported on morphology, in vitro biocompatibility, and immune 
response of tissue-engineered decellular porcine ureteral scaf-
folds, treated with different crosslinking agents. CDI crosslinked 
scaffolds exhibited a crucial M2-macrophage phenotype switch, 
activated MMP3, and inactivated TIMP1 in  vivo. The results 
suggested constructive remodeling processes and an improved 
integration of ureteral scaffolds into their surrounding tissue after 
implantation. These results were supported by in vitro results: a 
high infiltration of different cells was observed in CDI and GP 
scaffolds. The sum of the data suggests that CDI offered most 
benefits for crosslinking ECM scaffolds. The results of the present 
study help to develop a new biocompatible ureteral xenograft. 
However, biomechanical data are necessary to investigate a ureteral 
scaffold. In the future, we will design experiments to investigate 
biomechanical characteristics of decellularized tissue compared to 
native. Furthermore, studies such as large animal models should 
clarify the functionality of segmental CDI crosslinked ureteral 
scaffolds in the ureteral location. If this approach is successful, 
decellular ureteral scaffolds could be an important therapeutic tool 
for a wide range of applications (e.g., malignant tumor, ureteral 
stenosis, ureteral atresia, etc.).
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